Diabetic Ketoacidosis Market Size, Share, Scope & Forecast To 2027 Top Key Players are- Biocon, Merck, Novo Nordisk, Bristol-Myers Squibb, AstraZeneca, Etc
Technological advancements in diabetic ketoacidosis treatment, significant prevalence of target diseases, and rising private & government funding for new drug discovery are expected to be some major drivers for the market
View full press release